EQRx to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 03 2022 - 8:00AM
EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company
committed to developing and delivering important new medicines to
patients at radically lower prices, today announced that Melanie
Nallicheri, chief executive officer, will present virtually during
the 40th Annual J.P. Morgan Healthcare Conference on Monday,
January 10 at 3:45 p.m. ET.
A live and archived webcast of the presentation will be
available by visiting the Investors section of the Company’s
website at investors.eqrx.com.
About EQRxEQRx is a new type of pharmaceutical
company committed to developing and delivering innovative medicines
to patients at radically lower prices. Launched in January 2020,
EQRx is purpose-built, at scale, with a growing catalog of
medicines in development in high-cost drug categories and emerging
partnerships with leading payers and providers. Leveraging
cutting-edge science and technology and strategic partnerships with
stakeholders from across the healthcare system, EQRx aims to
provide innovative, patent-protected medicines more efficiently and
cost-effectively than ever before. To learn more,
visit www.eqrx.com and follow us on social media:
Twitter: @EQRxInc, LinkedIn,
Instagram: @eqrxinc.
EQRx™ and Remaking Medicine™ are trademarks of EQRx, Inc.
EQRx Contacts:
Media:Dan Budwick1ABdan@1abmedia.com
Investors: investors@eqrx.com
EQRx (NASDAQ:EQRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
EQRx (NASDAQ:EQRX)
Historical Stock Chart
From Apr 2023 to Apr 2024